98%
921
2 minutes
20
Introduction: The Scored Patient-Generated Subjective Global Assessment (PG-SGA) is a multidimensional tool used to assess malnutrition and associated risk factors.
Objective: To evaluate the nutritional status of Brazilian cancer patients hospitalized using the Scored PG-SGA and to examine the correlations with selected nutritional parameters.
Methods: This observational study included 2.027 cancer patients aged over 18 years at a hospital of cancer, Brazil. All patients were assessed for nutritional status using the Brazilian PG-SGA and anthropometric measurements were evaluated.
Results: According to the PG-SGA global assessment categories, 56.2% (1.138) cancer patients were well-nourished, 29.3% (594) were moderately malnourished, and 14.4% (292) were severely malnourished. The average body mass index (BMI) was 23.7±5.49 kg/m², and the current weight was 66.34±58.07 kg. The PG-SGA, nutritional status and clinical variable assessed by PG-SGA, were all significantly correlated with body mass index (p < 0.005) and weigh < 0.005).
Conclusions: The Brazilian PG-SGA showed a 43.7% of malnourished cancer patients. The classification of severely malnourished by PG-SGA demonstrated strong positive correlations with BMI. Anthropometric parameters correlates with PG-SGA variable, weigh with sex, nausea, diarrhea, dysgeusia, diagnostics of cancer, fever and death and BMI with sex, food intake, nausea, diarrhea , dysgeusia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12374500 | PMC |
http://dx.doi.org/10.31557/APJCP.2025.26.6.2009 | DOI Listing |
Pediatr Blood Cancer
September 2025
Acute Myeloid Leukemia Sub-Committee, Association of Childhood Leukemia Study (JACLS), Japan.
Background: Relapsed or refractory cases of pediatric acute myeloid leukemia (AML) have poor outcomes despite advancements in chemotherapy and hematopoietic stem cell transplantation (HSCT). While a second HSCT is often a salvage option, its outcomes vary widely, and prognostic factors remain unclear.
Objectives: This study aimed to evaluate outcomes and identify prognostic factors in pediatric patients with AML who underwent multiple HSCTs.
Pediatr Blood Cancer
September 2025
Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA.
Moyamoya syndrome (MMS) is a chronic vasculopathy characterized by progressive stenosis of intracerebral arteries, leading to an increased risk of stroke. Children with Down syndrome (DS) are at an increased risk of co-occurring medical conditions, including MMS and leukemia. We report four patients with the triad of DS, MMS, and acute lymphoblastic leukemia (ALL).
View Article and Find Full Text PDFJ Cancer Surviv
September 2025
Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, 203 Lothrop St # 500, Pittsburgh, PA, 15213, USA.
Purpose: Despite its importance, little is known about the patterns and predictors of Survivorship Clinic attendance in head and neck cancer (HNC). We sought to determine the cumulative incidence of Survivorship Clinic attendance stratified by demographic, clinical, and socioeconomic factors, and to identify factors independently associated with attendance.
Methods: Our analysis population consisted of 2,252 patients diagnosed with primary HNC and seen at our institution's HNC Survivorship Clinic after completing treatment from 2016-2021.
Dig Dis Sci
September 2025
Department of Gastrointestinal Surgery, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63, Xinfeng Road, Meijiang District, Meizhou, 514031, Guangdong, China.
Ann Surg Oncol
September 2025
Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.
Background: RUNX3 acts as a tumor suppressor gene in non-small-cell lung cancer (NSCLC), yet its specific biological mechanism is still unclear. This study aimed to uncover tumor microenvironment (TME) changes in NSCLC with varying RUNX3 expression statuses through single-cell RNA sequencing.
Patients And Methods: In total, seven patients with NSCLC with detailed pathological data were involved, with three both paracancerous and cancerous tissue samples.